# FDA recall D-0732-2018

> **Vitalab Pharmacy, Inc** · Class II · drug recall initiated 2018-04-24.

## Product

Papaverine 30mg/Phentolamine 1.5mg/Prostaglandin 50mcg/mL, sterile injectable, ST3:Papaverine 40mg/Phentolamine 3mg/Prostaglandin 60mcg/mL, Vitalab Pharmacy, Inc.

## Reason for recall

Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.

## Distribution

The recalled product was distributed to patients throughout the United States.

## Key facts

- **Recall number:** D-0732-2018
- **Recalling firm:** Vitalab Pharmacy, Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-04-24
- **Report date:** 2018-05-16
- **Termination date:** 2020-01-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Phoenix, AZ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0732-2018

## Citation

> AI Analytics. FDA recall D-0732-2018. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-0732-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*